Related Experiment Video
Updated: Dec 13, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Inducing Apoptosis through Upregulation of p53: Structure-Activity Exploration of Anthraquinone Analogs
Abiodun Anifowose1, Ayodeji A Agbowuro1, Ravi Tripathi1
1Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Petit Science Center, 100 Piedmont Ave, Atlanta, GA 30303, United States.
Abstract:
We previously reported a series of p53-elevating anthraquinone compounds with considerable cytotoxicity for acute lymphatic leukemia (ALL) cells. To further develop this class of compounds, we examined the effect of a few key structural features on the anticancer structure-activity relationship in ALL cells. The active analogs showed comparable cytotoxicity and upregulation of p53 but did not induce significant downregulation of MDM2 as seen with the lead compound AQ-101, indicating the importance of the anthraquinone core scaffold for MDM2 regulation. The result from the current study not only contributes to the SAR framework of these anthraquinone derivatives but also opens up new chemical space for further optimization work.
Insights
New anthraquinone derivatives show cytotoxicity against acute lymphatic leukemia (ALL) cells by elevating p53. However, the anthraquinone core is crucial for regulating MDM2, guiding future drug development.
Area of Science:
- Medicinal Chemistry
- Oncology
- Molecular Biology
Background:
- Previous research identified p53-elevating anthraquinone compounds with cytotoxicity against acute lymphatic leukemia (ALL).
- Further investigation is needed to understand the structure-activity relationship (SAR) of these compounds for optimized therapeutic potential.
Purpose of the Study:
- To examine the impact of key structural features on the anticancer activity of anthraquinone derivatives in ALL cells.
- To elucidate the mechanism of action, specifically regarding p53 and MDM2 regulation.
Main Methods:
- Synthesis and evaluation of novel anthraquinone analogs.
- Assessment of cytotoxicity against ALL cell lines.
- Analysis of p53 and MDM2 protein levels via Western blotting or similar techniques.
Main Results:
- Active analogs demonstrated significant cytotoxicity and p53 upregulation in ALL cells.
- Unlike the lead compound AQ-101, these analogs did not significantly downregulate MDM2.
- The anthraquinone core scaffold was identified as essential for MDM2 regulation.
Conclusions:
- The anthraquinone core is critical for the MDM2-regulating activity of these compounds.
- The study provides a refined SAR framework for anthraquinone derivatives targeting ALL.
- New avenues for chemical space exploration and optimization of anticancer agents are identified.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle